THREE-DIMENSIONAL CELL QUANTIFICATION ASSAY  
UCLA Technology Available For Licensing

UCLA researchers in the Department of Bioengineering have developed a standardized assay for quantifying cells in 3D culture systems. It is the first such assay that meets the growing trend of 3D culture systems in biomedical and pharmaceutical research.

BACKGROUND:  In the fields of cancer biology, developmental biology and tissue engineering, three-dimensional (3D) culture systems are replacing conventional petri-dish cultures to better simulate in vivo environments. Taking advantage of the advances in material sciences and chemical engineering, 3D culture systems are 3D polymeric scaffolds that resemble extracellular matrix surrounding the cells' in vivo environments. On the other hand, there is still no standardized assay for quantifying cells in 3D culture systems. Current assays used in conventional 2D cultures rely on the measurement of metabolic activity, DNA-binding fluorophores, uptake of radioactive labels, or hemocytometry; however, these measurements correlate poorly with cell proliferation in 3D cultures. It is an unanswered challenge to develop a simple, standardized cell proliferation assay for 3D culture systems, which have been quickly adopted in biomedical research, bioengineering and pharmaceutical fields.

INNOVATION:  Researchers at UCLA have developed a standardized assay for quantifying cells in 3D culture systems. The assay uses a degrading reagent to breakdown polymeric materials and release cellular DNA and proteins into the solution on a microplate. Then, the amount of DNA is measured by a colorimetric assay using a common spectrophotometer. Finally, the number of cells is calculated from the absorbance values in reference to a constructed standard curve. The assay has been adapted for several different types of common 3-D matrices. The assay does not use either fluorophores or radioactive labels, eliminating the problem of poor correlations in 3D cell culture systems.

POTENTIAL APPLICATIONS 

ADVANTAGES

DEVELOPMENT-TO-DATE:  This invention has been developed to quantify cells for in vitro 3D cell cultures. Efforts are underway to further enhance sensitivity.

Reference: UCLA Case No. 2009-523

For additional technical details and current licensing
availability, please contact the following UCLA office:

UCLA Office of Intellectual Property
11000 Kinross Avenue, Suite #200
Los Angeles, CA 90095
Tel: 310-794-0558 Fax: 310-794-0638
email: ncd@research.ucla.edu
NCD URL:   http://www.research.ucla.edu/tech/ucla09-523.htm

Lead Inventor: Benjamin Wu

UCLA Technologies Available for Licensing
http://www.research.ucla.edu/oipa/industry

Copyright © 2009 The Regents of the University of California.

keywords: Biomedical, Cell proliferation assay, 3-D cell cultures uclancd ucla latest inventions technology top ten 10 technologies intellectual property patents technology transfer invention business card